4//SEC Filing
Herskowitz Neil 4
Accession 0001104659-24-062663
CIK 0001651407other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:31 PM ET
Size
6.9 KB
Accession
0001104659-24-062663
Insider Transaction Report
Form 4
Herskowitz Neil
Director
Transactions
- Award
COMMON STOCK
2024-05-14+32,051→ 67,174 total - Award
COMMON STOCK
2024-05-14+50,000→ 117,174 total
Footnotes (3)
- [F1]The 32,051 shares of restricted Common Stock will vest on May 14, 2027, subject to Mr. Herskowitz's continued service on the board on such date.
- [F2]Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board.
- [F3]The 50,000 shares of restricted Common Stock will vest according to the following schedule, subject to Mr. Herskowitz's continued service on the board on each date: one third on May 14, 2027, one third on May 14, 2028, and one third on May 14, 2029.
Documents
Issuer
Checkpoint Therapeutics, Inc.
CIK 0001651407
Entity typeother
Related Parties
1- filerCIK 0001298246
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 7:31 PM ET
- Size
- 6.9 KB